Prime Medicine, Inc. Balance Sheet
PRME / Health Care|5 years of annual SEC 10-K data (FY2020-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Prime Medicine, Inc. had $298M in total assets and $153M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | $182.5M | $41.6M | $187.6M | $185.4M | $37.0M |
| Current Assets | $211.9M | $143.0M | $296.6M | $270.6M | - |
| PP&E (Net) | $24.4M | $22.7M | $19.0M | $4.9M | - |
| Total Assets | $297.5M | $193.9M | $360.3M | $301.9M | - |
| Current Liabilities | $38.0M | $56.4M | $26.7M | $58.0M | - |
| Shareholders' Equity | $153.1M | $133.1M | $316.3M | -$156.2M | $2.3M |